Delcath Systems Inc (DCTH)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Jennifer K. Simpson
Employees:
43
1633 BROADWAY, SUITE 22C, NEW YORK, NY 10019
(212) 489-2100

Delcath Systems, Inc. is a pharmaceutical and medical device company, which focuses on oncology and liver cancer therapy. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. It is designed to administer concentrated regional chemotherapy to the liver. The company was founded on August 5, 1988 and is headquartered in New York, NY.

Data derived from most recent annual or quarterly report
Market Cap 74.813 Million Shares Outstanding7.356 Million Avg 30-day Volume 17.234 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 25.18 / 8.28 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from DCTH instead.

View recent insider trading info

Funds Holding DCTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PADULA CHRISTINE SEE REMARKS

  • Officer
30,000 2021-09-01 2

STOLL ROGER G PHD

  • Director
9,000 2021-08-05 2

MICHEL GERARD J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
125,000 2021-08-05 4

CZEREPAK ELIZABETH

  • Director
9,000 2021-08-05 2

PURPURA JOHN CHIEF OPERATING OFFICER

  • Officer
45,000 2021-08-05 4

SALAMON STEVEN A J

  • Director
9,000 2021-08-05 9

SYLVESTER JOHN RICHARD

  • Director
9,000 2021-08-05 2

AHARON GIL

  • Director
9,000 2021-08-05 5

ROSALIND ADVISORS, INC.

  • Director
421,500 2021-06-30 7

RUECKERT WILLIAM DODGE

  • Director
6,014 2020-05-08 0

TAGLIETTI MARCO

  • Director
6,001 2020-05-08 0

KECK BARBRA SEE REMARKS

  • Officer
12,851 2020-05-06 0

SIMPSON JENNIFER K. PRESIDENT AND CEO

  • Officer
  • Director
25,021 2020-05-06 0

PEDDER SIMON

  • Director
0 2019-02-01 0

PHILIPS LAURA A

  • Director
205,299 2015-07-22 0

LANGER DENNIS

  • Director
20,000 2015-06-10 0

KOPLEWICZ HAROLD S

  • Director
45,052 2015-06-10 0

WATSON DOUGLAS G

  • Director
7,938 2014-07-10 0

LEUNG GABRIEL

  • Director
21,485 2014-07-07 0

KONIDARIS TASOS

  • Director
11,678 2014-07-07 0

BREGE LAURA

  • Director
11,678 2014-07-07 0

GRAHAM PETER J EVP; GENERAL COUNSEL

  • Officer
0 2013-11-14 0

MIAO GRAHAM G INTERIM CO-CEO & PRES.EVP, CFO

  • Officer
0 2013-11-14 0

APPLING WILLIAM M EVP, R&D AND GLOBAL OPERATIONS

  • Officer
0 2013-07-15 0

GAGO AGUSTIN V EVP GLOBAL SALES & MARKETING

  • Officer
0 2013-03-11 0

HOBBS EAMONN P PRESIDENT AND CEO

  • Officer
  • Director
0 2013-03-11 0

MAPES HAROLD EXEC. V. P., GLOBAL OPERATIONS

  • Officer
0 2013-03-11 0

KANDARPA KRISHNA EXEC. V.P., CHIEF MEDICAL OFF.

  • Officer
0 2013-03-11 0

LADD ROBERT

  • Director
700,828 2012-06-15 0

MCDONALD DAVID CHIEF FINANCIAL OFFICER

  • Officer
47,706 2011-03-10 0

CONTAG PAMELA REILLY

  • Director
8,507 2010-12-01 0

TANEY RICHARD

  • Director
211,485 2009-12-10 0

RIFKIN JASON ANDREW SR. VP CLINICAL OPER. & SECY

  • Officer
0 2009-10-12 0

LEWIS JONATHAN

  • Director
10,000 2008-06-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PADULA CHRISTINE - Officer SEE REMARKS

2021-10-19 13:20:24 -0400 2021-09-01 A 30,000 a 30,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DELCATH SYSTEMS INC DCTH 2021-10-26 18:45:03 UTC -7.9483 8.0183 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 18:15:03 UTC -7.9483 8.0183 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 17:45:03 UTC -7.9483 8.0183 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 17:15:03 UTC -7.9483 8.0183 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 16:45:04 UTC -7.9729 8.0429 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 16:15:03 UTC -7.9729 8.0429 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 15:45:03 UTC -7.9729 8.0429 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 15:15:03 UTC -7.9729 8.0429 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 14:45:03 UTC -7.9401 8.0101 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 14:15:05 UTC -7.9401 8.0101 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 13:45:03 UTC -7.9401 8.0101 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 13:15:03 UTC -7.9401 8.0101 55000
DELCATH SYSTEMS INC DCTH 2021-10-26 12:45:03 UTC -7.9401 8.0101 55000
DELCATH SYSTEMS INC DCTH 2021-10-25 22:15:03 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 21:45:03 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 21:15:03 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 20:45:03 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 20:15:03 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 19:45:04 UTC -7.9401 8.0101 7000
DELCATH SYSTEMS INC DCTH 2021-10-25 19:15:03 UTC -7.9401 8.0101 7000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments